Related Articles
High mobility group AT‑hook 2 and c‑MYC as potential prognostic factors in pancreatic ductal adenocarcinoma
circular RNAs 0000515 and 0011385 as potential biomarkers for disease monitoring and determining prognosis in pancreatic ductal adenocarcinoma
PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma
Derived neutrophil/lymphocyte ratio predicts gemcitabine therapy outcome in unresectable pancreatic cancer
High HDAC9 is associated with poor prognosis and promotes malignant progression in pancreatic ductal adenocarcinoma